Nerve block vs lidocaine drip: which eases pain after breast reduction?
NCT ID NCT07687069
First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time
Summary
This study compares two ways to manage pain after breast reduction surgery: a nerve block (ESPB) using bupivacaine, and an intravenous lidocaine drip given during surgery. Both aim to reduce pain, lower opioid use, and improve recovery quality. The trial includes 80 women scheduled for non-cancer breast reduction, and measures recovery scores and pain levels in the first 24 hours.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- bupivacaine (nerve block) and lidocaine (intravenous infusion)
- What this could lead to
- If one method proves better or equal, it could simplify pain management after breast reduction, reducing opioid needs and speeding recovery.
- What could go wrong
- This is a small, single-center study (80 people). Results may not apply to all patients, and both methods carry risks like allergic reactions or nerve damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 80 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 75 years
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * ASA physical status I-III * Scheduled for elective breast reduction surgery for non-oncological indications Exclusion Criteria: * Refusal or inability to provide written informed consent * History of chronic somatic or neuropathic pain * Current psychiatric disorders or ongoing treatment with antidepressant medications * Poorly controlled cardiovascular disease * Known allergy or intolerance to amide local anesthetics, including lidocaine and bupivacaine * Current alcohol abuse or substance use disorder
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast hypertrophy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre of Postgraduate Medical Education,Department of Anesthesia and Intensive Care
Warsaw, 01-813, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.